Ligand Pharmaceuticals Incorporated
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2008 | — | $-10.4M | $28.8M |
| Dec 2009 | — | $3.7M | $16.0M |
| Jun 2010 | — | — | $3.2M |
| Sep 2010 | — | — | $3.8M |
| Dec 2010 | — | $-4.9M | $3.3M |
| Mar 2011 | — | — | $6.0M |
| Jun 2011 | — | $5.9M | $3.4M |
| Sep 2011 | — | $3.1M | $2.3M |
| Dec 2011 | — | $8.2M | $7.0M |
| Mar 2012 | — | — | $9.8M |
| Jun 2012 | — | $17.5M | $8.9M |
| Sep 2012 | — | $21.2M | $7.0M |
| Dec 2012 | $27.5M | $26.5M | $12.4M |
| Mar 2013 | — | $30.6M | $5.0M |
| Jun 2013 | — | $39.3M | $5.9M |
| Sep 2013 | — | $44.8M | $3.3M |
| Dec 2013 | — | $49.6M | $11.6M |
| Mar 2014 | — | $65.0M | $13.0M |
| Jun 2014 | — | $64.2M | $14.5M |
| Sep 2014 | — | $44.4M | $180.7M |
| Dec 2014 | — | $26.3M | $160.2M |
| Mar 2015 | — | $35.1M | $165.8M |
| Jun 2015 | — | $69.1M | $108.2M |
| Sep 2015 | — | $266.8M | $93.8M |
| Dec 2015 | — | $237.3M | $97.4M |
| Mar 2016 | — | $364.6M | $31.3M |
| Jun 2016 | — | $329.8M | $61.4M |
| Sep 2016 | — | $338.3M | $86.6M |
| Dec 2016 | — | $341.3M | $18.8M |
| Mar 2017 | — | $371.8M | $10.6M |
| Jun 2017 | — | $385.1M | $60.2M |
| Sep 2017 | — | $403.2M | $32.7M |
| Dec 2017 | — | $399.8M | $20.6M |
| Mar 2018 | — | $481.1M | $51.0M |
| Jun 2018 | — | $619.8M | $151.5M |
| Sep 2018 | — | $699.5M | $115.6M |
| Dec 2018 | — | $560.9M | $117.2M |
| Mar 2019 | — | $1.08B | $105.1M |
| Jun 2019 | — | $1.04B | $273.0M |
| Sep 2019 | — | $850.6M | $225.3M |
| Dec 2019 | — | $767.2M | $71.5M |
| Mar 2020 | — | $661.9M | $117.5M |
| Jun 2020 | — | $695.0M | $115.2M |
| Sep 2020 | — | $697.8M | $456.9M |
| Dec 2020 | — | $709.5M | $47.6M |
| Mar 2021 | — | $745.8M | $31.9M |
| Jun 2021 | — | $786.5M | $21.9M |
| Sep 2021 | — | $812.1M | $23.4M |
| Dec 2021 | — | $821.2M | $19.5M |
| Mar 2022 | — | $793.2M | $15.0M |
| Jun 2022 | — | $802.4M | $5.3M |
| Sep 2022 | — | $816.3M | $4.1M |
| Dec 2022 | — | $597.5M | $45.0M |
| Mar 2023 | — | $646.3M | $88.7M |
| Jun 2023 | — | $664.9M | $28.4M |
| Sep 2023 | — | $667.9M | $19.3M |
| Dec 2023 | — | $700.9M | $23.0M |
| Mar 2024 | — | $806.5M | $50.1M |
| Jun 2024 | — | $775.2M | $18.1M |
| Sep 2024 | — | $841.2M | $63.6M |
| Dec 2024 | — | $830.4M | $72.3M |
| Mar 2025 | — | $795.6M | $48.0M |
| Jun 2025 | — | $827.3M | $67.7M |
| Sep 2025 | — | $950.2M | $139.4M |
| Dec 2025 | — | $1.02B | $174.9M |
| Mar 2026 | — | $997.3M | $115.1M |
| Jun 2026 | $1.13B | $967.5M | $1.01B |